Most of the insulin used by people today is made by bacteria that have been genetically modified to produce insulin that is identical to insulin made in the human pancreas, according to the National ...

Danaher faces revenue pressure and rising leverage despite strong market exposure, making its high valuation harder to ...

Guwahati, have developed a groundbreaking method to produce human insulin using Pseudomonas fluorescens, a safe and efficient ...

Modular Medical (Nasdaq:MODD) announced that it received Institutional Review Board (IRB) approval to study its ...

The Seattle-based biotech company aims to make new drug discovery faster and cheaper by using AI to simulate the results from ...

Global disparities in access to insulin and diabetes technologies impact glycemic outcomes in children with type 1 diabetes. Centers with universal reimbursement for diabetes technologies achieve ...

Researchers at IIT-Guwahati have developed a novel method to produce human insulin utilizing Pseudomonas fluorescens, making ...

In Medicare, insulin is covered under Medicare Part D, a Medicare Advantage prescription drug (MAPD) plan, or, in some cases, Medicare Part B. Since 2023, the Inflation Reduction Act (IRA) has capped ...

From AI content generation to personalization at scale, technology is constantly breaking new barriers when it comes to connecting marketers and audiences. New tools and platforms leveraging ...

The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance ...

Insulin-producing cells can be genetically modified to hide from the immune system. People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life ...

About The Study: This cross-sectional study found that HbA1c levels were associated with the accessibility of modern diabetes technologies and insulin. Efforts to ensure universal accessibility are ...